• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

射血分数中间值的心衰:欧洲心脏病学会指南对心衰新分类的利弊。

Heart failure with mid-range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines.

机构信息

Cardiothoracic Department, Civil Hospitals; Department of Medical and Surgical Specialities, Radioloogical Sciences, Public Health, University of Brescia, Brescia, Italy.

Department of Medicine, Duke University Medical Center, Durham, NC, USA.

出版信息

ESC Heart Fail. 2020 Apr;7(2):381-399. doi: 10.1002/ehf2.12586. Epub 2020 Apr 1.

DOI:10.1002/ehf2.12586
PMID:32239646
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7160484/
Abstract

Currently, the assessment of left ventricular ejection fraction (LVEF) is the cornerstone of the classification of patients with heart failure (HF). The mid-range LVEF (HFmrEF) category was identified in an attempt to uncover specific characteristics of these patients. So far, the analysis of trials, registries, and observational studies have demonstrated that patients with mid-range LVEF belong to a patient cohort with generally intermediate clinical profile as compared with other groups but with a remarkable variety of intrinsic phenotypes. This is due to the limitations of LVEF as the sole criterion to categorize patients with HF and characterize their prognosis, above all when it is >40%. To better define the HFmrEF phenotype, it is reasonable to consider other parameters, such as LVEF changes over time, HF aetiology, co-morbidities, and other imaging parameters. A multiparametric evaluation may contextualize a patient with HFmrEF in a more defined phenotype with a specific prognosis.

摘要

目前,左心室射血分数(LVEF)的评估是心力衰竭(HF)患者分类的基石。中范围 LVEF(HFmrEF)类别是为了揭示这些患者的特定特征而确定的。到目前为止,对试验、登记处和观察性研究的分析表明,与其他组相比,中范围 LVEF 的患者属于一般临床特征处于中间水平的患者队列,但具有显著不同的内在表型。这是由于 LVEF 作为唯一标准来对 HF 患者进行分类并描述其预后的局限性所致,尤其是当 LVEF >40%时。为了更好地定义 HFmrEF 表型,可以考虑其他参数,例如 LVEF 随时间的变化、HF 病因、合并症和其他成像参数。多参数评估可以将 HFmrEF 患者置于具有特定预后的更明确表型中。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d033/7160484/099b6ed8a777/EHF2-7-381-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d033/7160484/b7ff24903dfe/EHF2-7-381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d033/7160484/aa59930a0ce9/EHF2-7-381-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d033/7160484/099b6ed8a777/EHF2-7-381-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d033/7160484/b7ff24903dfe/EHF2-7-381-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d033/7160484/aa59930a0ce9/EHF2-7-381-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d033/7160484/099b6ed8a777/EHF2-7-381-g003.jpg

相似文献

1
Heart failure with mid-range ejection fraction: pro and cons of the new classification of Heart Failure by European Society of Cardiology guidelines.射血分数中间值的心衰:欧洲心脏病学会指南对心衰新分类的利弊。
ESC Heart Fail. 2020 Apr;7(2):381-399. doi: 10.1002/ehf2.12586. Epub 2020 Apr 1.
2
Heart Failure With Mid-Range (Borderline) Ejection Fraction: Clinical Implications and Future Directions.心力衰竭伴中间范围(边缘)射血分数:临床意义与未来方向。
JACC Heart Fail. 2017 Nov;5(11):763-771. doi: 10.1016/j.jchf.2017.06.013. Epub 2017 Oct 11.
3
Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid-range ejection fraction.射血分数中间值的心衰患者的流行病学、病理生理学和临床转归。
Eur J Heart Fail. 2017 Dec;19(12):1597-1605. doi: 10.1002/ejhf.879. Epub 2017 Jun 14.
4
Epidemiology and one-year outcomes in patients with chronic heart failure and preserved, mid-range and reduced ejection fraction: an analysis of the ESC Heart Failure Long-Term Registry.慢性心力衰竭伴射血分数保留、中间范围和降低患者的流行病学和一年结局:ESC 心力衰竭长期注册研究分析。
Eur J Heart Fail. 2017 Dec;19(12):1574-1585. doi: 10.1002/ejhf.813. Epub 2017 Apr 6.
5
Heart failure with mid-range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).射血分数中间值的心衰:一种明确的临床实体?来自强化与标准药物治疗充血性心力衰竭老年患者的试验(TIME-CHF)的见解。
Eur J Heart Fail. 2017 Dec;19(12):1586-1596. doi: 10.1002/ejhf.798. Epub 2017 Mar 15.
6
Heart failure with mildly reduced ejection fraction: emerging frontiers in clinical characteristics, prognosis, and treatment.射血分数轻度降低的心力衰竭:临床特征、预后和治疗的新前沿。
Rev Cardiovasc Med. 2022 Jan 18;23(1):30. doi: 10.31083/j.rcm2301030.
7
Clinical characteristics, one-year change in ejection fraction and long-term outcomes in patients with heart failure with mid-range ejection fraction: a multicentre prospective observational study in Catalonia (Spain).伴有中间范围射血分数的心力衰竭患者的临床特征、射血分数一年变化及长期结局:在加泰罗尼亚(西班牙)进行的一项多中心前瞻性观察研究。
BMJ Open. 2017 Dec 21;7(12):e018719. doi: 10.1136/bmjopen-2017-018719.
8
Effect of digoxin in patients with heart failure and mid-range (borderline) left ventricular ejection fraction.地高辛对心力衰竭伴左心室射血分数中间值(边缘值)患者的影响。
Eur J Heart Fail. 2018 Jul;20(7):1139-1145. doi: 10.1002/ejhf.1160. Epub 2018 Mar 1.
9
Heart Failure with Mid-Range Ejection Fraction - State of the Art.射血分数中间值心力衰竭 - 最新进展。
Arq Bras Cardiol. 2019 Jul 15;112(6):784-790. doi: 10.5935/abc.20190079.
10
Changes in the Left Ventricular Ejection Fraction and Outcomes in Hospitalized Heart Failure Patients with Mid-range Ejection Fraction: A Prospective Observational Study.左心室射血分数变化与中等射血分数心力衰竭住院患者结局的关系:一项前瞻性观察研究。
Intern Med. 2021 May 15;60(10):1509-1518. doi: 10.2169/internalmedicine.6388-20. Epub 2020 Dec 15.

引用本文的文献

1
Impact of comorbid constipation on the survival of patients with heart failure: a multicenter, prospective cohort study conducted in Japan.合并便秘对心力衰竭患者生存的影响:一项在日本开展的多中心前瞻性队列研究。
Front Cardiovasc Med. 2025 Jan 14;11:1470216. doi: 10.3389/fcvm.2024.1470216. eCollection 2024.
2
Prognostic Value of Epicardial Adipose Tissue in Heart Failure With Mid-Range and Preserved Ejection Fraction: A Multicenter Study.心外膜脂肪组织在射血分数中度降低和保留的心衰中的预后价值:一项多中心研究
J Am Heart Assoc. 2024 Dec 17;13(24):e036789. doi: 10.1161/JAHA.124.036789. Epub 2024 Dec 14.
3
Does the Measurement of Ejection Fraction Still Make Sense in the HFpEF Framework? What Recent Trials Suggest.

本文引用的文献

1
Predicting Arrhythmia Risk in Dilated Cardiomyopathy Using Genetic Mutation Status.利用基因突变状态预测扩张型心肌病的心律失常风险
J Am Coll Cardiol. 2019 Sep 17;74(11):1491-1493. doi: 10.1016/j.jacc.2019.07.034.
2
Angiotensin-Neprilysin Inhibition in Heart Failure with Preserved Ejection Fraction.血管紧张素-脑啡肽酶抑制剂在射血分数保留的心力衰竭中的应用。
N Engl J Med. 2019 Oct 24;381(17):1609-1620. doi: 10.1056/NEJMoa1908655. Epub 2019 Sep 1.
3
Heart Failure and Atrial Fibrillation, Like Fire and Fury.心力衰竭与心房颤动:如影随形。
在射血分数保留的心力衰竭(HFpEF)框架下,射血分数测量是否仍有意义?近期试验的启示。
J Clin Med. 2023 Jan 15;12(2):693. doi: 10.3390/jcm12020693.
4
Development of algorithms for determining heart failure with reduced and preserved ejection fraction using nationwide electronic healthcare records in the UK.利用英国全国范围的电子医疗记录开发用于确定射血分数降低型和射血分数保留型心力衰竭的算法。
Open Heart. 2022 Nov;9(2). doi: 10.1136/openhrt-2022-002142.
5
Feasibility of the contraction-relaxation coupling index in outcome prediction for patients with acute heart failure.收缩-舒张耦联指数对急性心力衰竭患者预后预测的可行性。
ESC Heart Fail. 2022 Apr;9(2):1228-1238. doi: 10.1002/ehf2.13797. Epub 2022 Jan 3.
6
Suppression of acute heart failure rehospitalization by biventricular pacing in wide QRS and mid-range ejection fraction.双心室起搏抑制宽 QRS 伴中间射血分数的心衰再住院率。
ESC Heart Fail. 2021 Dec;8(6):4705-4709. doi: 10.1002/ehf2.13585. Epub 2021 Sep 9.
7
Heart Failure with Mid-Range Ejection Fraction - A Temporary Condition or a Specific Group?射血分数中等范围的心力衰竭——一种暂时状态还是一个特定群体?
Arq Bras Cardiol. 2021 Aug;117(2):307-308. doi: 10.36660/abc.20210482.
8
Beta-blocker treatment in heart failure patients with atrial fibrillation: challenges and perspectives.心力衰竭合并心房颤动患者的β受体阻滞剂治疗:挑战与展望。
J Geriatr Cardiol. 2021 May 28;18(5):362-375. doi: 10.11909/j.issn.1671-5411.2021.05.008.
9
Heart Failure With Mid-range Ejection Fraction: A Distinctive Subtype or a Transitional Stage?射血分数处于中等范围的心力衰竭:一种独特的亚型还是一个过渡阶段?
Front Cardiovasc Med. 2021 May 25;8:678121. doi: 10.3389/fcvm.2021.678121. eCollection 2021.
10
Are HFpEF and HFmrEF So Different? The Need to Understand Distinct Phenotypes.射血分数保留的心力衰竭和射血分数轻度降低的心力衰竭有如此大的差异吗?理解不同表型的必要性。
Front Cardiovasc Med. 2021 May 21;8:676658. doi: 10.3389/fcvm.2021.676658. eCollection 2021.
JACC Heart Fail. 2019 Jun;7(6):447-456. doi: 10.1016/j.jchf.2019.03.005.
4
Mechanical dyssynchrony: How do we measure it, what it means, and what we can do about it.机械不同步:如何测量,意味着什么,以及我们能做些什么。
J Nucl Cardiol. 2021 Oct;28(5):2174-2184. doi: 10.1007/s12350-019-01758-0. Epub 2019 May 29.
5
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of the Heart Failure Association of the European Society of Cardiology.2019 年心力衰竭临床实践更新:药物治疗、程序、设备和患者管理。欧洲心脏病学会心力衰竭协会专家共识会议报告。
Eur J Heart Fail. 2019 Oct;21(10):1169-1186. doi: 10.1002/ejhf.1531. Epub 2019 Aug 30.
6
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. Reply.达格列净与2型糖尿病患者的心血管结局。回复
N Engl J Med. 2019 May 9;380(19):1881-1882. doi: 10.1056/NEJMc1902837.
7
The continuous heart failure spectrum: moving beyond an ejection fraction classification.连续心力衰竭谱:超越射血分数分类。
Eur Heart J. 2019 Jul 1;40(26):2155-2163. doi: 10.1093/eurheartj/ehz158.
8
Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials.螺内酯在射血分数中等范围心力衰竭及射血分数保留心力衰竭中的疗效与安全性:一项随机临床试验的荟萃分析
Medicine (Baltimore). 2019 Mar;98(13):e14967. doi: 10.1097/MD.0000000000014967.
9
Prevalence and Prognostic Implications of Longitudinal Ejection Fraction Change in Heart Failure.心力衰竭中纵向射血分数变化的流行率和预后意义。
JACC Heart Fail. 2019 Apr;7(4):306-317. doi: 10.1016/j.jchf.2018.11.019. Epub 2019 Mar 6.
10
Innovative imaging methods in heart failure: a shifting paradigm in cardiac assessment. Position statement on behalf of the Heart Failure Association of the European Society of Cardiology.心力衰竭的创新影像学方法:心脏评估的范式转变。代表欧洲心脏病学会心力衰竭协会的立场声明。
Eur J Heart Fail. 2018 Dec;20(12):1615-1633. doi: 10.1002/ejhf.1330. Epub 2018 Nov 9.